Our study demonstrated that FOXM1 activated the MET/AKT signaling pathway by stimulating the transcription of MET in lung adenocarcinoma cells, and this effect was partially inhibited by PHA-665752. This evidence concerns the gene FOXM1 and lung adenocarcinoma.